Promotor methylation status of <scp>MAPK4</scp> is a novel epigenetic biomarker for prognosis of recurrence in patients with thymic epithelial tumors-Reference-Cited by-同舟云学术

Promotor methylation status of MAPK4 is a novel epigenetic biomarker for prognosis of recurrence in patients with thymic epithelial tumors

Author:

Guan Wei¹,Li Songlin²³,Zhang Zhimin⁴,Xiao He¹^ORCID,He Juan¹,Li Jian¹,He Xuan¹,Luo Jia¹,Liu Yun¹,Lei Lin¹,Ma Jungang¹,Chen Lizhao⁵,Chen Chuan¹^ORCID

Affiliation:

1. Department of Cancer Center, Daping Hospital Army Medical University Chongqing China

2. Cancer Center, Sichuan Provincial People's Hospital University of Electronic Science and Technology of China Chengdu China

3. Chinese Academy of Sciences Sichuan Translational Medicine Research Hospital Chengdu China

4. Cancer Center, Renmin Hospital of Wuhan University Wuhan Hubei China

5. Department of Neurosurgery, Daping Hospital Army Medical University Chongqing China

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

Reference28 articles.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Methods in DNA methylation array dataset analysis: A review;Computational and Structural Biotechnology Journal;2024-12